Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Apr 18, 2025
- Accession no.
- 0001773751-25-000124
- Filed
- Apr 18, 2025
- Trade date
- Apr 16, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.36M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2025 | Class A Common Stock | MOption exerciseAcquired | +17,001 | $2.43 | +$41,312.43 | 111,896 | Direct | |
| Apr 16, 2025 | Class A Common Stock | MOption exerciseAcquired | +16,667 | $2.43 | +$40,500.81 | 128,563 | Direct | |
| Apr 16, 2025 | Class A Common Stock | SSaleDisposed | −33,668 | $28.02F2 | −$943,377.36 | 94,895 | Direct | |
| Apr 16, 2025 | Class A Common Stock | SSaleDisposed | −2,792 | $28.31F3 | −$79,041.52 | 92,103 | Direct | |
| Apr 16, 2025 | Class A Common Stock | SSaleDisposed | −47,534 | $28.23F4 | −$1,341,884.82 | 332,728 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2025 | Class A Common Stock | MOption exerciseDisposed | −17,001 | $0.00 | $0 | 119,011 | Direct | |
| Apr 16, 2025 | Class A Common Stock | MOption exerciseDisposed | −16,667 | $0.00 | $0 | 1,173,066 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.83 - $28.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.15 - $28.525. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.885 - $28.605. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.